Skip to main content
Clinical Trials/IRCT2016042627615N1
IRCT2016042627615N1
Completed
Phase 2

Clinical trial on the effectiveness of oxytocin and sublingual administration of misoprostol in premature rupture of membranes before the onset of the active phase of labor in term pregnancies

Vice Chancellor for Research, Mashhad University of Medical Sciences0 sites86 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
premature rupture of membranes at term.
Sponsor
Vice Chancellor for Research, Mashhad University of Medical Sciences
Enrollment
86
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice Chancellor for Research, Mashhad University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Premature rupture of membranes after 37 weeks of gestation; not being in the active phase of labor; Bishop score below six; cephalic presentation (vertex); singleton pregnancy; no evidence of clinical or laboratory signs confirming chorioamnionitis before the intervention; confirmation of the normal status of the fetal heart.
  • Exclusion criteria: Prior history of uterine scar; placenta previa; unstable status of the fetal heart; non\-cephalic presentation; sensitivity to misoprostol; history of glaucoma in misoprostol users; contraindication to vaginal delivery (e.g., narrow pelvis and genital herpes), and 8\) parity \= 5\.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials